CAS 1039758-22-9

Fórmula: C33H31N3O6

InChI: InChI=1S/C33H31N3O6/c1-19-18-36(24-4-5-24)26-13-21(14-29(41-2)30(19)26)31(38)35-9-7-33(8-10-35)15-27(37)25-12-20(3-6-28(25)42-33)22-11-23(32(39)40)17-34-16-22/h3,6,11-14,16-18,24H,4-5,7-10,15H2,1-2H3,(H,39,40)

Chave InChI: WDBNGXLHMZSUEI-UHFFFAOYSA-N

SMILES: CC1=CN(C2=C1C(=CC(=C2)C(=O)N3CCC4(CC3)CC(=O)C5=C(O4)C=CC(=C5)C6=CC(=CN=C6)C(=O)O)OC)C7CC7

MK-4074

CAS: 1039758-22-9

MK-4074

Fórmula: C₃₃H₃₁N₃O₆

Pureza: 99.04%

Peso molecular: 565.62

Ref: 54-OR1108059

MK-4074

CAS: 1039758-22-9

MK-4074 is a liver-specific acetyl-CoA carboxylase ACC1 and ACC2 inhibitor(IC50 of 3 nM).

Fórmula: C₃₃H₃₁N₃O₆

Cor e Forma: Solid

Peso molecular: 565.6157

Ref: TM-T12062

MK-4074

CAS: 1039758-22-9

Fórmula: C₃₃H₃₁N₃O₆

Pureza: 99.04%

Peso molecular: 565.6157

Ref: IN-DA01EOH5

MK-4074

CAS: 1039758-22-9

MK-4074 is an acetyl-CoA carboxylase (ACC) inhibitor, which is a compound originally developed by pharmaceutical research entities focusing on metabolic disorders. Acetyl-CoA carboxylase is a key enzyme in the biosynthesis of fatty acids, playing a critical role in the regulation of lipid metabolism. By inhibiting this enzyme, MK-4074 lowers the levels of malonyl-CoA, subsequently reducing fatty acid synthesis and increasing fatty acid oxidation.

Fórmula: C₃₃H₃₁N₃O₆

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 565.6 g/mol

Ref: 3D-PRB75822